DOCSLIB.ORG

Tissue and Host Tropism of Influenza Viruses: Importance of Quantitative Analysis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Tissue and Host Tropism of Influenza Viruses: Importance of Quantitative Analysis Science in China Series C: Life Sciences www.scichina.com life.scichina.com © 2009 SCIENCE IN CHINA PRESS www.springer.com/scp www.springerlink.com Review Tissue and host tropism of influenza viruses: Importance of quantitative analysis ZHANG Hong1,2 1 Z-BioMed, Inc., Rockville, MD 20855, USA; 2 Department of Respiratory Medicine, Affiliated Hospital of Zunyi Medical College, Zunyi 563003, China It is generally accepted that human influenza viruses preferentially bind to cell-surface glycoproteins/ glycolipids containing sialic acids in α2,6-linkage; while avian and equine influenza viruses preferen- tially bind to those containing sialic acids in α2,3-linkage. Even though this generalized view is accurate for H3 subtype isolates, it may not be accurate and absolute for all subtypes of influenza A viruses and, therefore, needs to be reevaluated carefully and realistically. Some of the studies published in major scientific journals on the subject of tissue tropism of influenza viruses are inconsistent and caused confusion in the scientific community. One of the reasons for the inconsistency is that most studies were quantitative descriptions of sialic acid receptor distributions based on lectin or influenza virus immunohistochemistry results with limited numbers of stained cells. In addition, recent studies indicate that α2,3- and α2,6-linked sialic acids are not the sole receptors determining tissue and host tropism of influenza viruses. In fact, determinants for tissue and host tropism of human, avian and animal influenza viruses are more complex than what has been generally accepted. Other factors, such as glycan topology, concentration of invading viruses, local density of receptors, lipid raft microdomains, coreceptors or sialic acid-independent receptors, may also be important. To more efficiently control the global spread of pandemic influenza such as the current circulating influenza A H1N1, it is crucial to clarify the determinants for tissue and host tropism of influenza viruses through quantitative analysis of experimental results. In this review, I will comment on some conflicting issues related to tissue and host tropism of influenza viruses, discuss the importance of quantitative analysis of lectin and influenza virus immunohistochemistry results and point out directions for future studies in this area, which should lead to a better understanding of tissue and host tropism of influenza viruses. tissue and host tropism, influenza viruses, sialic acid receptors, quantitative analysis The influenza viruses belong to the Orthomyxoviridae associated with high morbidity and mortality in people family and are enveloped animal viruses containing a of all ages, caused millions of deaths in the previous segmented single-stranded RNA genome[1,2]. They are three influenza pandemics, is the cause of the current classified into three types, A, B and C, based on their influenza H1N1 pandemic and has the potential to cause immunologically distinct nucleoprotein and matrix more pandemics in the future[3,4]. protein antigens. Type A influenza viruses are further A new human influenza virus could initiate as an grouped into antigenic subtypes according to their avian or animal influenza virus that adapts to humans specific surface glycoproteins hemagglutinin (HA) and through accumulation of mutations or as a hybrid influ- neuraminidase (NA). Influenza A occurs in humans, other mammals, and birds and sixteen distinct HA Received October 1, 2009; accepted November 11, 2009 subtypes and nine NA subtypes are currently recognized. doi: 10.1007/s11427-009-0161-x Influenza A attracts the most attention because it is †Corresponding author (email: [email protected]) Citation: ZHANG Hong. Tissue and host tropism of influenza viruses: Importance of quantitative analysis. Sci China Ser C-Life Sci, 2009, 52(12): 1101-1110, doi: 10.1007/s11427-009-0161-x enza virus containing a combination of genes derived At this stage, the influenza H1N1 pandemic can still be from an avian, an animal and a human influenza virus. characterized as being moderate in terms of severity and Therefore, influenza pandemics arise when a new mortality rate. The epidemiology, molecular biology, influenza virus emerges from human, avian or animal pathology, and pathogenic factors of influenza viruses influenza viruses or from reassortants of them, infects including H5N1 in humans have been comprehensively humans, and spreads efficiently among people. The first reviewed recently[8−14]. This article will briefly review transmission of the highly pathogenic H5N1 avian the generalized view of receptors for influenza viruses, influenza A virus directly from chickens to humans in comment on some conflicting issues related to tissue and Hong Kong was reported in 1997[5]. As of 31 August host tropism of influenza viruses, discuss the importance 2009, a total of 440 laboratory-confirmed human cases of quantitative analysis of lectin and influenza virus of avian influenza A (H5N1) virus infections from 15 immunohistochemistry results and point out directions countries have been reported to WHO and 262 of them for future studies in this area. (59.5%) have been fatal (www.who.int). In China, 25 of the 38 confirmed cases (65.8%) have been fatal. Among 1 Generalized view of receptors for the 45 confirmed cases (12 deaths) reported to WHO in influenza viruses 2009, 7 were from China and 4 of them were fatal. The generalized view is that avian influenza viruses These events demonstrate that avian influenza viruses replicate in the gastrointestinal tract of the host and can infect human directly and China is an important preferentially bind to cell-surface glycoproteins or country for the surveillance, prevention and control of glycolipids containing sialic acids in α2,3-linkage potential influenza pandemics. Continued circulation of (SAα2,3); while human influenza viruses replicate in the H5N1 and other avian influenza viruses in Asia shows host’s respiratory tract and bind to respiratory epithelial that a future pandemic from avian influenza is a real cells via sialic acids attached to glycoproteins or glycoli- threat. pids containing sialic acids in α2,6-linkage (SAα2,6). The current circulating influenza A H1N1 viruses Hundreds of articles including many reviews related to were probably originated from the combination of six influenza virus receptors have been published during last gene segments (PB2, PB1, PA, HA, NP, and NS1) from 20 years. Many review articles and several articles swine influenza H1N2 viruses circulating in the USA published in major scientific journals such as Science, from 1999 to 2001 (nucleotide sequence similarities Nature and Nature Medicine made generalized statemen- >96%) and two gene segments (NA and M1) from swine ts about influenza virus receptors and cited two original influenza viruses circulating in Europe from 1985 to articles published in 1983[15,16]. Here are some examples: 1999 (nucleotide sequence similarities >93%)[6]. The “Human and avian influenza A viruses differ in their gene segments of these influenza A H1N1 viruses could recognition of host cell receptors: the former preferential- also be traced back to human or avian origins if those ly recognize receptors with saccharides terminating in nucleotide sequences with similarities lower than 93% were considered. Since the first report of the swine sialic acid-α2,6-galactose (SAα2,6Gal), whereas the [17] influenza H1N1 in April 2009[7], there have been over latter prefer those ending in SAα2,3Gal” ; “Avian 526060 cases and at least 6770 deaths (1.29%) reported influenza viruses bind to cell-surface glycoproteins or to the WHO from all regions of the world (www. who. glycolipids containing terminal sialyl-galactosyl resi- int). The WHO Director-General raised the level of dues linked by 2-3-linkages [Neu5Ac(α2-3)Gal], whereas influenza pandemic alert from phase 5 to phase 6 on human viruses, including the earliest available isolates June 11, 2009 following the advice from the Emergency from 1957 and 1968 pandemics, bind to receptors that Committee which concluded that the criteria for a contain terminal 2-6-linked sialyl-galactosyl moieties [18] pandemic had been met. Currently, pandemic H1N1 [Neu5Ac(α2-6)Gal]” ; “HA binds to receptors influenza virus continues to be the predominant circula- containing glycans with terminal sialic acids, where ting virus of influenza in the world and all pandemic their precise linkage determines species preference. A H1N1 2009 influenza viruses sequenced so far have switch in receptor specificity from sialic acids connected been antigenically and genetically very similar to the to galactose in α2-3 linkages (avian) to α2-6 linkages first sequenced new influenza virus (A/California/7/2009). (human) is a major obstacle for influenza A viruses to 1102 ZHANG H. Sci China Ser C-Life Sci | Dec. 2009 | vol. 52 | no. 12 | 1101-1110 cross the species barrier and to adapt to a new host”[19]; extent, to be dependent on the species…” (true for H3 “Human viruses of the H1, H2 and H3 subtypes that are subtype isolates only) could have evolved to become known to have caused pandemics in 1918, 1957, and generalized statements such as “human influenza viruses 1968, respectively, recognize α2,6-linked sialic acid”[20]; preferentially recognize receptors with SAα2,6Gal, and “Human influenza strains preferentially bind to whereas avian influenza viruses preferentially recognize sialic acid residues linked to galactose by the α2,6 receptors with SAα2,3Gal” (implying isolates of all HA linkage, while avian and equine influenza strains subtypes). recognize sialic acid linked to galactose by α2,3 In another article of Rogers et al., the sequencing linkage.”[21] bands showing mutations of CTG-leucine (human specific) In one of their original articles published in 1983, to CAG-glutamine (avian specific) or ATG-methionine Rogers et al.[15] modified human type B erythrocytes to (specific for both human and avian receptors) at amino contain sialyloligosaccharides of defined sequence with acid 226 of HA1 were not clear enough to make defini- different sialyltransferases purified from porcine tive conclusions[16].
Load more

Recommended publications
  • Modeling Infectious Disease in Mice: Co-Adaptation and the Role of Host-Specific Ifnc Responses
    Opinion Modeling Infectious Disease in Mice: Co-Adaptation and the Role of Host-Specific IFNc Responses Jo¨ rn Coers1*, Michael N. Starnbach1, Jonathan C. Howard2 1 Department of Microbiology and Molecular Genetics, Harvard Medical School, Boston, Massachusetts, United States of America, 2 Institute for Genetics, University of Cologne, Cologne, Germany The advantages of the mouse as a inability of a pathogen to colonize the and rodents, binds complement inhibitory model organism in biomedical research non-typical host effectively. Colonization molecules of either host species and evades are many. The molecular and genetic often relies on species-specific interactions both human and rodent serum-mediated toolbox developed for the mouse over the of microbial ligands with host cell recep- killing [4]. This example illustrates a last 100 years enables researchers to tors. For example, the bacterial effector general principle: a pathogen must be able manipulate and study gene function in internalin A expressed by Listeria monocyto- to endure or overcome innate immune vivo almost at will. Time and time again, genes binds to the host E-cadherin receptor responses that drastically interfere with its scientific findings obtained through the use to mediate bacterial internalization, an survival and/or transmission to another of mouse models have proven to be essential step for the microbe to breach the suitable host. Pathogens must, therefore, relevant to human health. The field of intestinal epithelial barrier after oral have evolved subversion strategies for all immunology in particular has profited ingestion [2]. A single amino acid change the innate immune mechanisms that, if tremendously from the powers of the in the mouse ortholog of E-cadherin unrestricted, would result in their demise.
    [Show full text]
  • Is the ZIKV Congenital Syndrome and Microcephaly Due to Syndemism with Latent Virus Coinfection?
    viruses Review Is the ZIKV Congenital Syndrome and Microcephaly Due to Syndemism with Latent Virus Coinfection? Solène Grayo Institut Pasteur de Guinée, BP 4416 Conakry, Guinea; [email protected] or [email protected] Abstract: The emergence of the Zika virus (ZIKV) mirrors its evolutionary nature and, thus, its ability to grow in diversity or complexity (i.e., related to genome, host response, environment changes, tropism, and pathogenicity), leading to it recently joining the circle of closed congenital pathogens. The causal relation of ZIKV to microcephaly is still a much-debated issue. The identification of outbreak foci being in certain endemic urban areas characterized by a high-density population emphasizes that mixed infections might spearhead the recent appearance of a wide range of diseases that were initially attributed to ZIKV. Globally, such coinfections may have both positive and negative effects on viral replication, tropism, host response, and the viral genome. In other words, the possibility of coinfection may necessitate revisiting what is considered to be known regarding the pathogenesis and epidemiology of ZIKV diseases. ZIKV viral coinfections are already being reported with other arboviruses (e.g., chikungunya virus (CHIKV) and dengue virus (DENV)) as well as congenital pathogens (e.g., human immunodeficiency virus (HIV) and cytomegalovirus (HCMV)). However, descriptions of human latent viruses and their impacts on ZIKV disease outcomes in hosts are currently lacking. This review proposes to select some interesting human latent viruses (i.e., herpes simplex virus 2 (HSV-2), Epstein–Barr virus (EBV), human herpesvirus 6 (HHV-6), human parvovirus B19 (B19V), and human papillomavirus (HPV)), whose virological features and Citation: Grayo, S.
    [Show full text]
  • Improved Bacterial Recombineering by Parallelized Protein Discovery
    Improved bacterial recombineering by parallelized protein discovery Timothy M. Wanniera,1, Akos Nyergesa,b, Helene M. Kuchwaraa, Márton Czikkelyb, Dávid Baloghb, Gabriel T. Filsingera, Nathaniel C. Bordersa, Christopher J. Gregga, Marc J. Lajoiea, Xavier Riosa, Csaba Pálb, and George M. Churcha,1 aDepartment of Genetics, Harvard Medical School, Boston, MA 02115; and bSynthetic and Systems Biology Unit, Institute of Biochemistry, Biological Research Centre, Szeged HU-6726, Hungary Edited by Susan Gottesman, National Institutes of Health, Bethesda, MD, and approved April 17, 2020 (received for review January 30, 2020) Exploiting bacteriophage-derived homologous recombination pro- recombineering, is the molecular mechanism that drives MAGE cesses has enabled precise, multiplex editing of microbial genomes and DIvERGE (4, 32, 33). This method was first described in and the construction of billions of customized genetic variants in a E. coli, and is most commonly promoted by the expression of bet single day. The techniques that enable this, multiplex automated ge- (here referred to as Redβ) from the Red operon of Escherichia nome engineering (MAGE) and directed evolution with random ge- phage λ (5, 6, 34). Redβ is an ssDNA-annealing protein (SSAP) nomic mutations (DIvERGE), are however, currently limited to a whose role in recombineering is to anneal ssDNA to compli- handful of microorganisms for which single-stranded DNA-annealing mentary genomic DNA at the replication fork. Although im- proteins (SSAPs) that promote efficient recombineering have been provements to recombineering efficiency have been made (7–9), identified. Thus, to enable genome-scale engineering in new hosts, the core protein machinery has remained constant, with Redβ efficient SSAPs must first be found.
    [Show full text]
  • Pathogen Genetics: S. Aureus Multi-Host Tropism
    RESEARCH HIGHLIGHTS IN BRIEF GENETIC TESTING Genetic risk and statin preventative therapy Mega, Stitziel et al. test the clinical use of a multi-locus genetic risk score including a composite of 27 genetic variants associated with coronary heart disease. In community-based and primary or secondary prevention studies, they find that a higher genetic risk score is associated with increased risk of incident or recurrent coronary heart disease events, adjusted for clinical risk factors. Those in the highest genetic risk score categories derived greater benefits from statin preventative therapy, with greater relative and absolute disease risk reductions in randomized controlled trials for primary and secondary prevention. Although further testing in stratified prospective trials will be needed to directly test the clinical benefit of using a genetic risk score as the basis of selective statin therapy, the current study provides an indicator of how genetic screening may prove useful in identifying subpopulations that are more likely to benefit from preventative therapy. ORIGINAL RESEARCH PAPER Mega, J. L., Stitziel , N. O. et al. Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials. The Lancet http://dx.doi.org/10.1016/S0140- 6736(14)61730-X (2015) PATHOGEN GENETICS S. aureus multi-host tropism The Staphylococcus aureus clonal complex CC121 is a common cause of human skin and soft-tissue infections, as well as the source of a recent epidemic in rabbits. Viana et al. track the evolution of the multi-host tropism of this lineage. Phylogenetic analysis based on whole-genome sequences of a global collection of CC121 clinical strains showed a high level of diversity for the strains isolated from human cases, whereas the strains isolated from rabbits fell into a single clade.
    [Show full text]
  • How Host Cells Defend Against Influenza a Virus Infection
    viruses Review Host–Virus Interaction: How Host Cells Defend against Influenza A Virus Infection Yun Zhang 1 , Zhichao Xu and Yongchang Cao * State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen University, Guangzhou 510006, China; [email protected] (Y.Z.); [email protected] (Z.X.) * Correspondence: [email protected]; Tel.: +86-020-39332938 Received: 28 February 2020; Accepted: 25 March 2020; Published: 29 March 2020 Abstract: Influenza A viruses (IAVs) are highly contagious pathogens infecting human and numerous animals. The viruses cause millions of infection cases and thousands of deaths every year, thus making IAVs a continual threat to global health. Upon IAV infection, host innate immune system is triggered and activated to restrict virus replication and clear pathogens. Subsequently, host adaptive immunity is involved in specific virus clearance. On the other hand, to achieve a successful infection, IAVs also apply multiple strategies to avoid be detected and eliminated by the host immunity. In the current review, we present a general description on recent work regarding different host cells and molecules facilitating antiviral defenses against IAV infection and how IAVs antagonize host immune responses. Keywords: influenza A virus; innate immunity; adaptive immunity 1. Introduction Influenza A virus (IAV) can infect a wide range of warm-blooded animals, including birds, pigs, horses, and humans. In humans, the viruses cause respiratory disease and be transmitted by inhalation of virus-containing dust particles or aerosols [1]. Severe IAV infection can cause lung inflammation and acute respiratory distress syndrome (ARDS), which may lead to mortality. Thus, causing many influenza epidemics and pandemics, IAV has been a threat to public health for decades [2].
    [Show full text]
  • The SARS-Cov-2 Spike Protein Has a Broad Tropism for Mammalian ACE2 Proteins 2 3 Carina Conceicao*1, Nazia Thakur*1, Stacey Human1, James T
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.17.156471; this version posted June 18, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins 2 3 Carina Conceicao*1, Nazia Thakur*1, Stacey Human1, James T. Kelly1, Leanne Logan1, 4 Dagmara Bialy1, Sushant Bhat1, Phoebe Stevenson-Leggett1, Adrian K. Zagrajek1, Philippa 5 Hollinghurst1,2, Michal Varga1, Christina Tsirigoti1, John A. Hammond1, Helena J. Maier1, Erica 6 Bickerton1, Holly Shelton1, Isabelle Dietrich1, Stephen C. Graham3, Dalan Bailey¥1 7 8 1 The Pirbright Institute, Woking, Surrey, GU24 0NF, UK 9 2 Department of Microbial Sciences, Faculty of Health and Medical Sciences, University of 10 Surrey, Guildford, GU2 7XH, UK 11 3 Department of Pathology, University of Cambridge, Tennis Court Road, Cambridge, CB2 12 1QP, UK 13 14 * These authors contributed equally to the work 15 ¥ Corresponding author: [email protected] 16 17 Abstract 18 19 SARS-CoV-2 emerged in late 2019, leading to the COVID-19 pandemic that continues to 20 cause significant global mortality in human populations. Given its sequence similarity to SARS- 21 CoV, as well as related coronaviruses circulating in bats, SARS-CoV-2 is thought to have 22 originated in Chiroptera species in China. However, whether the virus spread directly to 23 humans or through an intermediate host is currently unclear, as is the potential for this virus 24 to infect companion animals, livestock and wildlife that could act as viral reservoirs.
    [Show full text]
  • Virus-Mediated Cell-Cell Fusion
    International Journal of Molecular Sciences Review Virus-Mediated Cell-Cell Fusion Héloïse Leroy 1,2,3, Mingyu Han 1,2,3 , Marie Woottum 1,2,3 , Lucie Bracq 4 , Jérôme Bouchet 5 , Maorong Xie 6 and Serge Benichou 1,2,3,* 1 Institut Cochin, Inserm U1016, 75014 Paris, France; [email protected] (H.L.); [email protected] (M.H.); [email protected] (M.W.) 2 Centre National de la Recherche Scientifique CNRS, UMR8104, 75014 Paris, France 3 Faculty of Health, University of Paris, 75014 Paris, France 4 Global Health Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland; lucie.bracq@epfl.ch 5 Laboratory Orofacial Pathologies, Imaging and Biotherapies UR2496, University of Paris, 92120 Montrouge, France; [email protected] 6 Division of Infection and Immunity, University College London, London WC1E 6BT, UK; [email protected] * Correspondence: [email protected] Received: 20 November 2020; Accepted: 14 December 2020; Published: 17 December 2020 Abstract: Cell-cell fusion between eukaryotic cells is a general process involved in many physiological and pathological conditions, including infections by bacteria, parasites, and viruses. As obligate intracellular pathogens, viruses use intracellular machineries and pathways for efficient replication in their host target cells. Interestingly, certain viruses, and, more especially, enveloped viruses belonging to different viral families and including human pathogens, can mediate cell-cell fusion between infected cells and neighboring non-infected cells. Depending of the cellular environment and tissue organization, this virus-mediated cell-cell fusion leads to the merge of membrane and cytoplasm contents and formation of multinucleated cells, also called syncytia, that can express high amount of viral antigens in tissues and organs of infected hosts.
    [Show full text]
  • A Vital Gene for Modified Vaccinia Virus Ankara Replication in Human Cells COMMENTARY Gerd Suttera,B,1
    COMMENTARY A vital gene for modified vaccinia virus Ankara replication in human cells COMMENTARY Gerd Suttera,b,1 Vaccinia virus (VACV), the prototype orthopoxvirus, is the first live viral vaccine used to protect against small- pox, one of the most feared infectious diseases of hu- mans (1). This outstanding achievement was possible because even as the various orthopoxviruses evolved and diversified they often retained major parts of their virion composition in common. In consequence, pro- ductive infection with one orthopoxvirus, VACV, effec- tively immunizes the host against infection by other orthopoxviruses including variola virus, the closely re- lated agent of smallpox. Successful vaccination against smallpox positively correlated with the productive rep- lication of VACV in the skin of vaccinated individuals. However, on occasion the inoculation of live VACV had risk because the vaccine virus could develop general- ized infections and cause other severe adverse events following vaccination (2). Ever since, research with VACV Fig. 1. Schematic overview of the MVA life cycle and important virus proteins – seeks to elucidate the many secrets of this unique virus to overcome intracellular host restrictions in human cells. As all poxviruses, MVA human host interaction. What makes VACV efficiently replicates in the cytoplasm of infected cells. Following entry, the virus replication grow in human cells? This might sound like a simple comprises three steps of viral RNA and protein synthesis defined as expression question since the growth tropism of many other viruses of early, intermediate, and late viral genes. Production and processing of late structural proteins result in the morphogenesis of new infectious virions is largely determined by the binding of a specific viral enveloped by one or two additional lipid membranes.
    [Show full text]
  • Functional and Genetic Analysis of Viral Receptor ACE2 Orthologs Reveals a Broad Potential Host Range of SARS-Cov-2
    Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2 Yinghui Liua,1, Gaowei Hub,1, Yuyan Wangb,1, Wenlin Rena,1, Xiaomin Zhaoa,1, Fansen Jia, Yunkai Zhub, Fei Fengb, Mingli Gonga, Xiaohui Jua, Yuanfei Zhub, Xia Caib, Jun Lanc, Jianying Guoa, Min Xiea, Lin Donga, Zihui Zhua, Jie Naa, Jianping Wud,e, Xun Lana, Youhua Xieb, Xinquan Wangc,f, Zhenghong Yuanb,2, Rong Zhangb,2, and Qiang Dinga,f,2 aCenter for Infectious Disease Research, School of Medicine, Tsinghua University, 100084 Beijing, China; bKey Laboratory of Medical Molecular Virology, Biosafety Level 3 Laboratory, School of Basic Medical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China; cSchool of Life Sciences, Tsinghua University, 100084 Beijing, China; dKey Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, 310024 Hangzhou, China; eInstitute of Biology, Westlake Institute for Advanced Study, 310024 Hangzhou, China; and fBeijing Advanced Innovation Center for Structural Biology, Tsinghua University, 100084 Beijing, China Edited by Peter Palese, Icahn School of Medicine at Mount Sinai, New York, New York, and approved February 5, 2021 (received for review December 10, 2020) The pandemic of COVID-19, caused by SARS-CoV-2, is a major entry (5, 7). Following binding of ACE2, the S protein is sub- global health threat. Epidemiological studies suggest that bats sequently cleaved by the host transmembrane serine protease 2 (Rhinolophus affinis) are the natural zoonotic reservoir for (TMPRSS2) to release the spike fusion peptide, promoting virus SARS-CoV-2. However, the host range of SARS-CoV-2 and interme- entry into target cells (7).
    [Show full text]
  • Bacterial Evolution: Bugs-To-Bunny in a Single-Hit Tropism Shift
    RESEARCH HIGHLIGHTS IN BRIEF VIRAL PATHOGENESIS Travelling in clusters Host-cell entry and exit are traditionally viewed as processes that viruses undergo as independent units. However, Chen et al. now describe a novel intercellular transport pathway, in which clusters of approximately 20 mature enterovirus particles, such as poliovirus, are packaged into phosphatidylserine (PS)-enriched vesicles and are transmitted in unison between cells in a non-lytic manner. Compared with free virus particles, transmission via vesicles led to a substantial increase in infection efficiency, even though in both cases cell entry was dependent on the receptor CD155. The increased infection efficiency might be due to interactions between the vesicles and host cell PS receptors, as vesicles in which PS was masked were not infectious. Aside from casting doubt on the paradigm that viruses enter and exit cells as independent units, these findings suggest that genetic cooperation might occur between individual enterovirus genomes. ORIGINAL RESEARCH PAPER Chen, Y.-H. et al. Phosphatidylserine vesicles enable efficient en bloc transmission of enteroviruses. Cell 160, 619–630 (2015) BACTERIAL EVOLUTION Bugs-to-bunny in a single-hit tropism shift The genetic changes that enable pathogens to jump from one host species to another, which often results in epidemic disease, are poorly understood. To identify the molecular basis of host adaptation, Penadés and colleagues traced the evolutionary history of Staphylococcus aureus ST121, which switched its host preference from humans to rabbits more than 40 years ago. Using whole-genome sequencing of both present-day and historical human and rabbit isolates, the authors found that only a single nonsynonymous mutation in the core genome was required and sufficient for host switching.
    [Show full text]
  • The Phylogenetic Range of Bacterial and Viral Pathogens of Vertebrates
    bioRxiv preprint doi: https://doi.org/10.1101/670315; this version posted June 13, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. The phylogenetic range of bacterial and viral pathogens of vertebrates Liam P. Shaw1,2,a, Alethea D. Wang1,3,a, David Dylus4,5,6, Magda Meier1,7, Grega Pogacnik1, Christophe Dessimoz4,5,6,8,9, Francois Balloux1 aCo-first authors Affiliations: 1 UCL Genetics Institute, University College London, London WC1E 6BT, UK; 2 Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, UK; 3 Canadian University Dubai, Sheikh Zayed Road, Dubai, United Arab Emirates 4 Department of Computational Biology, University of Lausanne, CH-1015 Lausanne, Switzerland 5 Center for Integrative Genomics, University of Lausanne, CH-1015 Lausanne, Switzerland 6 Swiss Institute of Bioinformatics, Génopode, CH-1015 Lausanne, Switzerland 7 Genetics and Genomic Medicine, University College London Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, United Kingdom 8 Centre for Life's Origins and Evolution, Department of Genetics Evolution & Environment, University College London, London WC1E 6BT, UK 9 Department of Computer Science, University College London, London WC1E 6BT, UK Correspondence: Liam P. Shaw ([email protected]) and Francois Balloux ([email protected]) Keywords: Host Range; Host Jumps; Emerging Infectious Diseases; Phylogenetics; Zoonotic diseases bioRxiv preprint doi: https://doi.org/10.1101/670315; this version posted June 13, 2019.
    [Show full text]
  • Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial
    Edinburgh Research Explorer Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance Citation for published version: Watson, K, Russell, CD, Baillie, JK, Dhaliwal, K, Fitzgerald, JR, Mitchell, TJ, Simpson, AJ, Renshaw, SA & Dockrell, DH 2020, 'Developing Novel Host-Based Therapies Targeting Microbicidal Responses in Macrophages and Neutrophils to Combat Bacterial Antimicrobial Resistance', Frontiers in Immunology, vol. 11, pp. 786. https://doi.org/10.3389/fimmu.2020.00786 Digital Object Identifier (DOI): 10.3389/fimmu.2020.00786 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Frontiers in Immunology Publisher Rights Statement: Copyright © 2020 Watson, Russell, Baillie, Dhaliwal, Fitzgerald, Mitchell, Simpson, Renshaw and Dockrell. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation.
    [Show full text]